Genetic Technology and Medicine | 基因技术与医学

📚 Genetic Technology and Medicine | 基因技术与医学

Genetic technology has transformed modern medicine by allowing scientists to read, copy, cut and edit DNA with precision. From the production of human insulin in bacteria to the development of gene therapies for inherited disorders, these tools are now central to diagnosis, drug development and personalised treatment. This article covers the core techniques and medical applications required for Cambridge A-Level Biology.

基因技术通过精确读取、复制、切割和编辑 DNA，彻底改变了现代医学。从利用细菌生产人胰岛素到开发针对遗传病的基因疗法，这些工具如今已成为诊断、药物研发和个性化治疗的核心。本文涵盖剑桥 A-Level 生物学所要求的核心技术及其医学应用。

---

1. Recombinant DNA: The Foundation | 重组 DNA：技术基石

Recombinant DNA technology involves joining DNA from two different sources to create a new genetic combination. In medicine, this allows a human gene such as the insulin gene to be inserted into a bacterial plasmid so that the bacterium produces a human protein.

重组 DNA 技术是指将来自两个不同来源的 DNA 连接起来，形成新的遗传组合。在医学上，这使人类基因（如胰岛素基因）能够插入细菌质粒中，从而让细菌生产人类蛋白质。

The key steps are isolation of the target gene, cutting vector and insert with restriction enzymes, ligation to form recombinant plasmids, transformation into host cells, and selection of successfully modified cells.

关键步骤包括：分离目标基因、用限制酶切割载体和插入片段、连接形成重组质粒、转化进入宿主细胞，以及筛选成功改造的细胞。

A promoter and a terminator must be included alongside the coding sequence to ensure the host cell transcribes the inserted gene efficiently. Without correct regulatory sequences, the gene may remain silent.

编码序列旁边必须包含启动子和终止子，以确保宿主细胞能有效转录插入的基因。如果缺少正确的调控序列，基因可能无法表达。

---

2. Restriction Enzymes and DNA Ligase | 限制酶与 DNA 连接酶

Restriction endonucleases cut DNA at specific recognition sequences, often producing sticky ends with short single-stranded overhangs. For example, EcoRI recognises the sequence GAATTC and cuts between G and A, leaving compatible sticky ends.

限制性内切酶在特定的识别序列处切割 DNA，通常产生带有短单链突出的粘性末端。例如，EcoRI 识别序列 GAATTC，并在 G 和 A 之间切割，留下互补的粘性末端。

Sticky ends are useful because fragments cut with the same enzyme have complementary overhangs and can base-pair with each other. DNA ligase then seals the sugar-phosphate backbones by forming phosphodiester bonds.

粘性末端非常有用，因为用同一种酶切割的片段具有互补的突出端，可以彼此碱基配对。随后 DNA 连接酶通过形成磷酸二酯键封闭糖-磷酸骨架。

In medical applications, restriction enzymes allow scientists to excise a specific gene such as the human insulin gene and insert it into a plasmid vector that carries the same sticky ends.

在医学应用中，限制酶使科学家能够切下特定基因（如人胰岛素基因），并将其插入带有相同粘性末端的质粒载体中。

---

3. Vectors: Plasmids and Viruses | 载体：质粒与病毒

A vector is a DNA molecule used to carry foreign genetic material into a host cell. Bacterial plasmids are the most common vectors in pharmaceutical production because they are small, easy to manipulate and replicate independently.

载体是用于将外源遗传物质导入宿主细胞的 DNA 分子。细菌质粒是药物生产中最常用的载体，因为它们体积小、易操作且能独立复制。

Useful plasmid vectors contain an origin of replication, a multiple cloning site, and selectable marker genes such as antibiotic resistance. Cells that take up the plasmid survive on antibiotic-containing agar, allowing identification of transformed colonies.

有用的质粒载体包含复制起点、多克隆位点以及抗生素抗性等选择标记基因。摄取质粒的细胞能在含抗生素的琼脂上存活，从而鉴定转化菌落。

Vector type | 载体类型	Use in medicine | 医学用途	Key feature | 关键特征
Plasmid | 质粒	Produce insulin, growth hormone | 生产胰岛素、生长激素	Small, easy to clone | 小、易克隆
Viral vector | 病毒载体	Gene therapy delivery | 基因治疗递送	Can enter human cells efficiently | 能高效进入人类细胞

---

4. PCR: Amplifying DNA for Diagnosis | PCR：扩增 DNA 用于诊断

The polymerase chain reaction (PCR) amplifies a specific DNA sequence rapidly in vitro. It is essential in medicine for detecting viral DNA or RNA, diagnosing genetic mutations, and preparing samples for sequencing.

聚合酶链式反应（PCR）可在体外快速扩增特定 DNA 序列。它在医学中对于检测病毒 DNA 或 RNA、诊断基因突变以及制备测序样本至关重要。

Each PCR cycle includes denaturation at about 95 °C to separate strands, annealing of primers at 50–65 °C, and extension by Taq polymerase at about 72 °C. Taq polymerase is heat-stable, so it survives the high denaturation temperatures.

每个 PCR 循环包括约 95 °C 变性使双链分离、50–65 °C 引物退火，以及约 72 °C 由 Taq 聚合酶延伸。Taq 聚合酶耐热，因此能在高温变性步骤中保持活性。

Primers are short single-stranded DNA molecules complementary to the boundaries of the target sequence. They define the region to be amplified and allow DNA polymerase to begin synthesis.

引物是与目标序列边界互补的短单链 DNA 分子。它们界定待扩增区域，并使 DNA 聚合酶能够启动合成。

---

5. DNA Sequencing and Genetic Diagnosis | DNA 测序与基因诊断

DNA sequencing determines the exact order of nucleotides in a DNA molecule. Modern high-throughput sequencing allows rapid analysis of whole genomes, which is used to identify disease-causing mutations in patients.

DNA 测序可确定 DNA 分子中核苷酸的精确顺序。现代高通量测序能快速分析整个基因组，用于识别患者体内的致病突变。

In genetic diagnosis, a patient’s DNA is compared with a reference sequence. If a mutation is found in a known disease gene, such as the CFTR gene in cystic fibrosis, clinicians can confirm a diagnosis or identify carriers.

在基因诊断中，将患者 DNA 与参考序列进行比较。如果在已知疾病基因（如囊性纤维化的 CFTR 基因）中发现突变，临床医生就可以确诊或识别携带者。

Sequencing also underpins personalised medicine by revealing specific alleles that affect drug metabolism. This allows doctors to select drugs and doses that are most likely to be safe and effective for an individual patient.

测序还通过揭示影响药物代谢的特定等位基因为个性化医疗提供基础。这使医生能够选择对个体患者最可能安全有效的药物和剂量。

---

6. Producing Therapeutic Proteins | 生产治疗性蛋白质

Before genetic engineering, insulin for diabetics was extracted from pig or cow pancreas. This animal insulin could cause allergic reactions and supply was limited. Recombinant human insulin produced by bacteria or yeast is now the standard treatment.

在基因工程出现之前，糖尿病患者的胰岛素是从猪或牛的胰腺中提取的。这种动物胰岛素可能引起过敏反应，且供应有限。由细菌或酵母生产的重组人胰岛素现已成为标准疗法。

To produce human insulin, the human insulin gene is inserted into a plasmid under a strong bacterial promoter. Transformed Escherichia coli cells are grown in fermenters, and the insulin protein is harvested and purified.

为了生产人胰岛素，将人胰岛素基因插入带有强细菌启动子的质粒中。转化的大肠杆菌细胞在发酵罐中培养，随后收获并纯化胰岛素蛋白。

Other therapeutic proteins produced by recombinant DNA technology include human growth hormone, clotting factors for haemophilia, and erythropoietin for anaemia. This approach avoids contamination with human pathogens and improves batch consistency.

通过重组 DNA 技术生产的其他治疗性蛋白质包括人生长激素、用于血友病的凝血因子以及用于贫血的红细胞生成素。这种方法避免了人类病原体污染，并提高了批次一致性。

---

7. Gene Therapy: Correcting Defects | 基因治疗：纠正缺陷

Gene therapy aims to treat or cure disease by introducing a functional gene into a patient’s cells. It is particularly promising for monogenic disorders caused by a single defective gene, such as severe combined immunodeficiency (SCID).

基因治疗旨在通过将功能基因导入患者细胞来治疗或治愈疾病。它对于由单个缺陷基因引起的单基因疾病（如重症联合免疫缺陷 SCID）尤其有前景。

Somatic gene therapy targets body cells, so the genetic change is not passed to offspring. Germline gene therapy would modify eggs, sperm or embryos and is illegal in most countries due to ethical concerns.

体细胞基因治疗针对体细胞，因此遗传改变不会传递给后代。生殖系基因治疗会修改卵子、精子或胚胎，由于伦理问题在大多数国家被禁止。

In ex vivo gene therapy, cells are removed from the patient, modified in the laboratory, and then returned. This is used for blood disorders because stem cells can be collected from bone marrow, corrected, and transplanted back.

在离体基因治疗中，从患者体内取出细胞，在实验室中改造后再输回体内。这用于血液疾病，因为可以从骨髓收集干细胞，进行修正后再移植回去。

---

8. Delivery Systems in Gene Therapy | 基因治疗的递送系统

A major challenge in gene therapy is delivering the therapeutic gene into the correct human cells. Viral vectors are often used because viruses have evolved to enter cells efficiently.

基因治疗的一大挑战是将治疗基因递送到正确的人类细胞中。病毒载体常被使用，因为病毒在进化中具备了高效进入细胞的能力。

Retroviruses integrate their genetic material into the host genome, enabling long-term expression. However, insertion near oncogenes can cause cancer. Adenoviruses do not integrate, so expression is temporary but avoids insertional mutagenesis.

逆转录病毒将其遗传物质整合到宿主基因组中，可实现长期表达。但插入位点若靠近致癌基因可能引发癌症。腺病毒不整合，因此表达是暂时的，但避免了插入突变。

Non-viral methods include liposomes that fuse with the cell membrane and deliver DNA directly. These are less efficient but generally safer and easier to produce on a large scale.

非病毒方法包括与细胞膜融合并直接递送 DNA 的脂质体。这些方法效率较低，但通常更安全，且更容易大规模生产。

---

9. CRISPR-Cas9: Precision Genome Editing | CRISPR-Cas9：精准基因组编辑

CRISPR-Cas9 is a genome editing tool adapted from a bacterial defence system. It uses a guide RNA complementary to the target DNA sequence and the Cas9 nuclease to create a double-strand break at a precise location.

CRISPR-Cas9 是一种改编自细菌防御系统的基因组编辑工具。它利用与目标 DNA 序列互补的向导 RNA 和 Cas9 核酸酶，在精确位置产生双链断裂。

The cell’s own repair machinery then repairs the break. Non-homologous end joining can disable a faulty gene, while homology-directed repair can insert a corrected sequence if a donor template is provided.

随后细胞自身的修复机制修复断裂。非同源末端连接可使缺陷基因失活，而同源定向修复若提供供体模板，则可插入正确序列。

In medicine, CRISPR is being investigated for treating sickle cell disease, beta-thalassaemia and certain cancers. Potential risks include off-target cuts in unintended parts of the genome, which must be carefully screened.

在医学上，CRISPR 正被研究用于治疗镰状细胞病、β-地中海贫血和某些癌症。潜在风险包括基因组非预期部位的脱靶切割，必须进行仔细筛查。

---

10. Genetic Testing and Personalised Medicine | 基因检测与个性化医疗

Genetic testing analyses DNA to identify mutations linked to disease. It can be used for prenatal diagnosis, newborn screening, carrier testing and predictive testing for adult-onset disorders such as Huntington disease.

基因检测通过分析 DNA 来识别与疾病相关的突变。它可用于产前诊断、新生儿筛查、携带者检测，以及对亨廷顿病等成年发病疾病的预测性检测。

Personalised medicine uses genetic information to tailor prevention and treatment. For example, breast cancer patients with HER2 overexpression respond well to trastuzumab, while those without this marker do not.

个性化医疗利用遗传信息来定制预防和治疗方案。例如，HER2 过表达的乳腺癌患者对曲妥珠单抗反应良好，而没有该标志物的患者则不然。

Pharmacogenomics studies how gene variants affect drug response. Variants in the CYP450 enzyme family can cause a patient to break down a drug too quickly or too slowly, influencing dosage and safety.

药物基因组学研究基因变异如何影响药物反应。CYP450 酶家族的变异可能导致患者分解药物过快或过慢，从而影响剂量和安全性。

---

11. Ethical and Safety Issues | 伦理与安全问题

Genetic technology raises ethical issues about privacy, consent and discrimination. Genetic information could be used by employers or insurers to discriminate against individuals with disease risk alleles.

基因技术引发了关于隐私、知情同意和歧视的伦理问题。遗传信息可能被雇主或保险公司用来歧视携带疾病风险等位基因的个体。

Gene therapy carries safety risks, including immune reactions to viral vectors, off-target mutations and the possibility of leukaemia if a vector inserts near an oncogene. Clinical trials require careful long-term monitoring.

基因治疗存在安全风险，包括对病毒载体的免疫反应、脱靶突变，以及载体插入致癌基因附近可能引发白血病的风险。临床试验需要仔细的长期监测。

Germline editing is particularly controversial because changes would be inherited by future generations. There is broad international agreement that heritable human genome editing should not proceed until safety and ethical concerns are resolved.

生殖系编辑尤其具有争议，因为改变会被后代遗传。国际社会普遍认为，在安全和伦理问题得到解决之前，不应进行可遗传的人类基因组编辑。

---

12. Key Exam Points and Summary | 考点总结

Students should be able to explain how restriction enzymes create sticky ends, how DNA ligase joins fragments, and why plasmids are useful cloning vectors. They must also describe the role of markers in selecting transformed cells.

学生应能解释限制酶如何产生粘性末端、DNA 连接酶如何连接片段，以及质粒为何是有用的克隆载体。他们还必须描述标记基因在选择转化细胞中的作用。

PCR steps, the role of Taq polymerase and primers, and applications in diagnosis should be linked to concrete examples such as detecting viral RNA after reverse transcription.

PCR 的步骤、Taq 聚合酶和引物的作用以及其在诊断中的应用，应与具体例子联系起来，例如反转录后检测病毒 RNA。

For medicine, candidates should compare the advantages of recombinant human insulin over animal insulin, outline the principles of somatic gene therapy, and discuss the benefits and risks of CRISPR-Cas9 in treating genetic disease.

在医学方面，考生应比较重组人胰岛素相对于动物胰岛素的优势，概述体细胞基因治疗的原理，并讨论 CRISPR-Cas9 在治疗遗传病中的益处与风险。

Published by TutorHao | Biology Revision Series | aleveler.com

更多咨询请联系16621398022（同微信）